Decreased vesicular acetylcholine transporter and α4β2 nicotinic receptor density in the rat brain following 192 IgG-saporin immunolesioning

Neuroscience Letters

Volumn 415, Issue 2, 2007, Pages 97-101

  Quinlivan, Mitchell ^a,b,c   Chalon, Sylvie ^a   Vergote, Jackie ^a   Henderson, Jasmine ^b   Katsifis, Andrew ^c   Kassiou, Michael ^b,d   Guilloteau, Denis ^a  

^a UNIVERSITÉ DE TOURS   (France)

^b UNIVERSITY OF SYDNEY   (Australia)

^c AUSTRALIAN NUCLEAR SCIENCE AND TECHNOLOGY ORGANISATION   (Australia)

^d UNIVERSITY OF SYDNEY   (Australia)

Author keywords

192 IgG saporin; *I A 85380; IBVM; Nicotinic acetylcholine receptor; Vesicular acetylcholine transporter

Indexed keywords

3 (2 AZETIDINYLMETHOXY)PYRIDINE; CYTISINE; EPIBATIDINE; IMMUNOGLOBULIN G; IODINE 123; IODINE 125; IODOBENZOVESAMICOL I 123; NICOTINIC RECEPTOR; SAPORIN; UNCLASSIFIED DRUG; VESAMICOL; VESICULAR ACETYLCHOLINE TRANSPORTER;

ALZHEIMER DISEASE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; AUTORADIOGRAPHY; CEREBELLUM; CHOLINERGIC NERVE CELL; CONTROLLED STUDY; DRUG RECEPTOR BINDING; DRUG UPTAKE; FEMALE; HIPPOCAMPUS; IN VITRO STUDY; IN VIVO STUDY; MOLECULAR IMAGING; NERVE DEGENERATION; NONHUMAN; PRIORITY JOURNAL; RADIOIODINATION; RAT; RECEPTOR DENSITY;

ANIMALS; ANTIBODIES, MONOCLONAL; AUTORADIOGRAPHY; AZETIDINES; BRAIN; FEMALE; IMMUNOTOXINS; IODINE RADIOISOTOPES; N-GLYCOSYL HYDROLASES; PIPERIDINES; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, NICOTINIC; STATISTICS, NONPARAMETRIC; TETRAHYDRONAPHTHALENES; VESICULAR ACETYLCHOLINE TRANSPORT PROTEINS;

EID: 33947133279     PISSN: 03043940     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neulet.2006.08.065     Document Type: Article

References (42)

1. Anderson D.J., and Arneric S.P. Nicotinic receptor binding of [3H]cytisine, [3H]nicotine and [3H]methylcarbamylcholine in rat brain. Eur. J. Pharmacol. 253 (1994) 261-267
2. Bednar I., Zhang X., Dastranj-Sedghi R., and Nordberg A. Differential changes of nicotinic receptors in the rat brain following ibotenic acid and 192-IgG saporin lesions of the nucleus basalis magnocellularis. Int. J. Dev. Neurosci. 16 (1998) 661-668
3. Chefer S.I., Horti A.G., Lee K.S., Koren A.O., Jones D.W., Gorey J.G., Links J.M., Mukhin A.G., Weinberger D.R., and London E.D. In vivo imaging of brain nicotinic acetylcholine receptors with 5-[123I]iodo-A-85380 using single photon emission computed tomography. Life Sci. 63 (1998) PL355-PL360
4. Court J., Martin-Ruiz C., Piggott M., Spurden D., Griffiths M., and Perry E. Nicotinic receptor abnormalities in Alzheimer's disease. Biol. Psychiatry 49 (2001) 175-184
5. Damaj M.I. Influence of gender and sex hormones on nicotine acute pharmacological effects in mice. J. Pharmacol. Exp. Ther. 296 (2001) 132-140
6. Donny E.C., Caggiula A.R., Rowell P.P., Gharib M.A., Maldovan V., Booth S., Mielke M.M., Hoffman A., and McCallum S. Nicotine self-administration in rats: estrous cycle effects, sex differences and nicotinic receptor binding. Psychopharmacology 151 (2000) 392-405
7. Efange S.M., Garland E.M., Staley J.K., Khare A.B., and Mash D.C. Vesicular acetylcholine transporter density and Alzheimer's disease. Neurobiol. Aging 18 (1997) 407-413
8. Everitt B.J., and Robbins T.W. Central cholinergic systems and cognition. Annu. Rev. Psychol. 48 (1997) 649-684
9. Geula C., and Mesulam M.M. Systematic regional variations in the loss of cortical cholinergic fibers in Alzheimer's disease. Cereb. Cortex 6 (1996) 165-177
10. Gilmor M.L., Counts S.E., Wiley R.G., and Levey A.I. Coordinate expression of the vesicular acetylcholine transporter and choline acetyltransferase following septohippocampal pathway lesions. J. Neurochem. 71 (1998) 2411-2420
11. Gilmor M.L., Erickson J.D., Varoqui H., Hersh L.B., Bennett D.A., Cochran E.J., Mufson E.J., and Levey A.I. Preservation of nucleus basalis neurons containing choline acetyltransferase and the vesicular acetylcholine transporter in the elderly with mild cognitive impairment and early Alzheimer's disease. J. Comp. Neurol. 411 (1999) 693-704
12. Gnadisch D., London E.D., Terry P., Hill G.R., and Mukhin A.G. High affinity binding of [3H]epibatidine to rat brain membranes. Neuroreport 10 (1999) 1631-1636
13. Gopalakrishnan M., Monteggia L.M., Anderson D.J., Molinari E.J., Piattoni-Kaplan M., Donnelly-Roberts D., Arneric S.P., and Sullivan J.P. Stable expression, pharmacologic properties and regulation of the human neuronal nicotinic acetylcholine alpha 4 beta 2 receptor. J. Pharmacol. Exp. Ther. 276 (1996) 289-297
14. Horti A.G., Koren A.O., Lee K.S., Mukhin A.G., Vaupel D.B., Kimes A.S., Stratton M., and London E.D. Radiosynthesis and preliminary evaluation of 5-[123/125I]iodo-3-(2(S)-azetidinylmethoxy)pyridine: a radioligand for nicotinic acetylcholine receptors. Nucl. Med. Biol. 26 (1999) 175-182
15. Jonasson Z., Cahill J.F.X., Tobey R.E., and Baxter M.G. Sexually dimorphic effects of hippocampal cholinergic differentiation in rats. Eur. J. Neurosci. 20 (2004) 3041-3053
16. Kassiou M., Eberl S., Meikle S.R., Birrell A., Constable C., Fulham M.J., Wong D.F., and Musachio J.L. In vivo imaging of nicotinic receptor upregulation following chronic (-)-nicotine treatment in baboon using SPECT. Nucl. Med. Biol. 28 (2001) 165-175
17. Koylu E., Demirgoren S., London E.D., and Pogun S. Sex difference in up-regulation of nicotinic acetylcholine receptors in rat brain. Life Sci. 61 (1997) PL185-PL190
18. Kuhl D.E., Minoshima S., Fessler J.A., Frey K.A., Foster N.L., Ficaro E.P., Wieland D.M., and Koeppe R.A. In vivo mapping of cholinergic terminals in normal aging, Alzheimer's disease, and Parkinson's disease. Ann. Neurol. 40 (1996) 399-410
19. Kulak J.M., Musachio J.L., McIntosh J.M., and Quik M. Declines in different beta2* nicotinic receptor populations in monkey striatum after nigrostriatal damage. J. Pharmacol. Exp. Ther. 303 (2002) 633-639
20. Lee M., Martin-Ruiz C., Graham A., Court J., Jaros E., Perry R., Iversen P., Bauman M., and Perry E. Nicotinic receptor abnormalities in the cerebellar cortex in autism. Brain 125 (2002) 1483-1495
21. Masson J., Sagné C., Hamon M., and Mestikawy E. Neurotransmitter transporters in the central nervous system. Pharmacol. Rev. 51 (1999) 439-464
22. Mesulam M.M. The cholinergic lesion of Alzheimer's disease: pivotal factor or side show?. Learn. Mem. 11 (2004) 43-49
23. Mukhin A.G., Gundisch D., Horti A.G., Koren A.O., Tamagnan G., Kimes A.S., Chambers J., Vaupel D.B., King S.L., Picciotto M.R., Innis R.B., and London E.D. 5-Iodo-A-85380, an alpha4beta2 subtype-selective ligand for nicotinic acetylcholine receptors. Mol. Pharmacol. 57 (2000) 642-649
24. Nakayama H., Shioda S., Nakajo S., Ueno S., Nakashima T., and Nakai Y. Immunocytochemical localization of nicotinic acetylcholine receptor in the rat cerebellar cortex. Neurosci. Res. 29 (1997) 233-239
25. Nordberg A. Nicotinic receptor abnormalities of Alzheimer's disease: therapeutic implications. Biol. Psychiatry 49 (2001) 200-210
26. Paterson D., and Nordberg A. Neuronal nicotinic receptors in the human brain. Prog. Neurobiol. 61 (2000) 75-111
27. Paxinos G., and Watson C. The Rat Brain In Stereotaxic Coordinates. fourth ed. (1998), Academic Press xxvi, 119 pp. of plates, 117 pp. of plates pp
28. Perry D.C., Xiao Y., Nguyen H.N., Musachio J.L., Davila-Garcia M.I., and Kellar K.J. Measuring nicotinic receptors with characteristics of alpha4beta2, alpha3beta2 and alpha3beta4 subtypes in rat tissues by autoradiography. J. Neurochem. 82 (2002) 468-481
29. Pogun S., Demirgoren S., Taskiran D., Kanit L., Yilmaz O., Koylu E.O., Balkan B., and London E.D. Nicotine modulates nitric oxide in rat brain. Eur. Neuropsychopharmacol. 10 (2000) 463-472
30. Rada E.M., Tharakan E.C., and Flood P. Volatile anesthetics reduce agonist affinity at nicotinic acetylcholine receptors in the brain. Anesth. Analg. 96 (2003) 108-111
31. Rossner S., Schliebs R., Hartig W., and Bigl V. 192IgG-saporin-induced selective lesion of cholinergic basal forebrain system: neurochemical effects on cholinergic neurotransmission in rat cerebral cortex and hippocampus. Brain Res. Bull. 38 (1995) 371-381
32. Rossner S., Schliebs R., Perez-Polo J.R., Wiley R.G., and Bigl V. Differential changes in cholinergic markers from selected brain regions after specific immunolesion of the rat cholinergic basal forebrain system. J. Neurosci. Res. 40 (1995) 31-43
33. Schank J.C. Do Norway rats (Rattus norvegicus) synchronize their estrous cycles?. Physiol. Behav. 72 (2001) 129-139
34. Sihver W., Gillberg P.G., and Nordberg A. Laminar distribution of nicotinic receptor subtypes in human cerebral cortex as determined by [3H](-)nicotine, [3H]cytisine and [3H]epibatidine in vitro autoradiography. Neuroscience 85 (1998) 1121-1133
35. Sihver W., Gillberg P.G., Svensson A.L., and Nordberg A. Autoradiographic comparison of 3H (-)nicotine, 3H cytisine and 3H epibatidine binding in relation to vesicular acetylcholine transport sites in the temporal cortex in Alzheimer's disease. Neuroscience 94 (1999) 685-696
36. Sorger D., Schliebs R., Kampfer I., Rossner S., Heinicke J., Dannenberg C., and Georgi P. In vivo [125I]-iodobenzovesamicol binding reflects cortical cholinergic deficiency induced by specific immunolesion of rat basal forebrain cholinergic system. Nucl. Med. Biol. 27 (2000) 23-31
37. Tribollet E., Bertrand D., Marguerat A., and Raggenbass M. Comparative distribution of nicotinic receptor subtypes during development, adulthood and aging: an autoradiographic study in the rat brain. Neuroscience 124 (2004) 405-420
38. Turner J.R., and Kellar K.J. Nicotinic cholinergic receptors in the rat cerebellum: multiple heteromeric subtypes. J. Neurosci. 25 (2005) 9258-9265
39. Waite J.J., Wardlow M.L., Chen A.C., Lappi D.A., Wiley R.G., and Thal L.J. Time course of cholinergic and monoaminergic changes in rat brain after immunolesioning with 192 IgG-saporin. Neurosci. Lett. 169 (1994) 154-158
40. Warpman U., and Nordberg A. Epibatidine and ABT 418 reveal selective losses of alpha 4 beta 2 nicotinic receptors in Alzheimer brains. Neuroreport 6 (1995) 2419-2423
41. Wiley R.G., Berbos T.G., Deckwerth T.L., Johnson Jr. E.M., and Lappi D.A. Destruction of the cholinergic basal forebrain using immunotoxin to rat NGF receptor: modeling the cholinergic degeneration of Alzheimer's disease. J. Neurol. Sci. 128 (1995) 157-166
42. Wong T.P., Debeir T., Duff K., and Cuello A.C. Reorganization of cholinergic terminals in the cerebral cortex and hippocampus in transgenic mice carrying mutated presenilin-1 and amyloid precursor protein transgenes. J. Neurosci. 19 (1999) 2706-2716